Scholarlink

Background <p>The prognostic relevance of tumor location in upper tract urothelial carcinoma (UTUC), particularly the difference between renal pelvic and ureteral tumors, remains controversial. This study aimed to clarify the impact of tumor location on stage-specific survival and recurrence patterns following radical nephroureterectomy (RNU), using a large multi-institutional cohort.</p> Methods <p>Patients diagnosed with UTUC who underwent RNU between 2003 and 2023 were retrospectively reviewed and categorized into the renal pelvic urothelial carcinoma (RPUC) group or the ureteral urothelial carcinoma (UUC) group. Propensity score matching was then applied to adjust for baseline clinicopathological factors between the RPUC and UUC groups. Cancer-specific survival (CSS), nonurothelial tract recurrence-free survival (NUTRFS), and recurrence patterns were compared, with subgroup analyses being conducted according to pathological T stage (pTa/Tis/T1, pT2, and pT3/4).</p> Results <p>We retrospectively analyzed 1,367 patients with UTUC. After propensity score matching, 5-year CSS and NUTRFS tended to be lower in the UUC group than in the RPUC group (CSS: 72% vs. 79%, <i>p</i> = 0.069; RFS: 55% vs. 62%, <i>p</i> = 0.072). In pT2 disease, outcomes were significantly worse in the UUC group (5-year CSS: 68% vs. 90%, <i>p</i> = 0.024; NUTRFS: 49% vs. 68%, <i>p</i> = 0.021). The UUC group also had significantly higher local recurrence rates at both pT2 and pT3/T4. In contrast, the RPUC group tended to have more distant metastases at pT3/4.</p> Conclusions <p>Tumor location in UTUC may influence stage-specific outcomes. These differences in outcomes underscore the need for individualized stage-specific management.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Stage-Specific Prognostic Impact of Tumor Location in Upper Tract Urothelial Carcinoma: A Propensity Score-Matched Analysis

  • 期刊论文

  • 发表日期：

    2026年4月6日

查看全文
  • Shigeki Koterazawa,
  • Toru Kanno,
  • Yuki Kita,
  • Takeshi Sano,
  • Toshifumi Takahashi,
  • Yuto Hattori,
  • Go Kobori,
  • Tomohiro Fukui,
  • Toshiya Akao,
  • Shotaro Hatano,
  • Kaoru Murakami,
  • Takayuki Sumiyoshi,
  • Kimihiko Masui,
  • Takayuki Goto,
  • Takashi Kobayashi,
  • Ryoichi Saito

摘要

Background

The prognostic relevance of tumor location in upper tract urothelial carcinoma (UTUC), particularly the difference between renal pelvic and ureteral tumors, remains controversial. This study aimed to clarify the impact of tumor location on stage-specific survival and recurrence patterns following radical nephroureterectomy (RNU), using a large multi-institutional cohort.

Methods

Patients diagnosed with UTUC who underwent RNU between 2003 and 2023 were retrospectively reviewed and categorized into the renal pelvic urothelial carcinoma (RPUC) group or the ureteral urothelial carcinoma (UUC) group. Propensity score matching was then applied to adjust for baseline clinicopathological factors between the RPUC and UUC groups. Cancer-specific survival (CSS), nonurothelial tract recurrence-free survival (NUTRFS), and recurrence patterns were compared, with subgroup analyses being conducted according to pathological T stage (pTa/Tis/T1, pT2, and pT3/4).

Results

We retrospectively analyzed 1,367 patients with UTUC. After propensity score matching, 5-year CSS and NUTRFS tended to be lower in the UUC group than in the RPUC group (CSS: 72% vs. 79%, p = 0.069; RFS: 55% vs. 62%, p = 0.072). In pT2 disease, outcomes were significantly worse in the UUC group (5-year CSS: 68% vs. 90%, p = 0.024; NUTRFS: 49% vs. 68%, p = 0.021). The UUC group also had significantly higher local recurrence rates at both pT2 and pT3/T4. In contrast, the RPUC group tended to have more distant metastases at pT3/4.

Conclusions

Tumor location in UTUC may influence stage-specific outcomes. These differences in outcomes underscore the need for individualized stage-specific management.